drugset / Trial / NCT04565678

A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants

NCT04565678 ↗

Phase 1 Completed 32 enrolled Agios Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to assess the relative bioavailability of the mitapivat coated granule formulation compared to the tablet formulation following a single oral dose of mitapivat under fasted conditions in healthy adult participants.

Timeline

Start
2020-09-21
Primary completion
2020-12-03
Completion
2020-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitapivat Small molecule — Oral

Indications

No indication recorded.